project id: TCGA-ESCA; case submitter id: TCGA-R6-A6KZ; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.93; rna integrity number: 8.8; age at index: 42; days to birth: -15512; days to death: 154; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1968; year of death: 2010; age at diagnosis: 15512; ajcc clinical m: M1; ajcc clinical n: NX; ajcc clinical stage: Stage IV; ajcc clinical t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Yes; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 1049; days to sample procurement: 0; initial weight: 1.0; sample id: b275ff0b-d309-4943-a003-7abbd5a27cce; sample submitter id: TCGA-R6-A6KZ-01A; portion id: 1941197b-adc2-432e-a5db-62a91157cd48; portion submitter id: TCGA-R6-A6KZ-01A-11; slide id: b886cfab-e8d0-4fa5-ad76-70704b66a4e0; slide submitter id: TCGA-R6-A6KZ-01Z-00-DX1; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 2.0; percent normal cells: 25.0; percent stromal cells: 10.0; percent tumor cells: 60.0; percent tumor nuclei: 75.0; section location: TOP;